Press release
Peptide CDMO Pharmaceutical Market Outlook Regional Insights North America Europe and Asia Pacific
Peptide CDMO (Pharmaceutical) Market
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1202
Peptide Contract Development and Manufacturing Organizations (CDMOs) focus on the biological synthesis of peptides, which are short chains of amino acids connected by peptide bonds. This process requires the precise sequential assembly of amino acids according to specific sequences, often necessitating the preservation of functional groups to maintain process fidelity. Peptide synthesis can be accomplished through a variety of approaches, including solid-phase synthesis, solution-phase synthesis, and recombinant DNA technology.
The rising incidence of chronic diseases has heightened the demand for advanced therapeutic solutions. Peptide-based drugs offer several advantages, including targeted modulation of biochemical pathways, high specificity, and the potential for reduced dosing requirements. As a result, the demand for peptide therapeutics is increasing across diverse medical domains, such as oncology, cardiovascular diseases, and diabetes management. CDMOs are pivotal in meeting this demand by delivering specialized capabilities in the development and large-scale manufacturing of peptide-based pharmaceutical products.
List of Prominent Players in the Peptide CDMO (Pharmaceutical) Market:
• AmbioPharm
• Auspep
• Bachem
• BCN Peptide
• CPC Scientific
• CBL- Chemical and Biopharmaceutical Laboratories
• Creative Peptides
• Chinese Peptide
• CSBio
• Corden Pharma
• PolyPeptide
• Hybio Pharmaceutical
• Peptide Institute
• Pepscan
• Almac
• Vivitide
• CreoSalus Inc
• ScinoPharm
• Senn Chemicals
• Wuxi AppTec
• Olon
• Belyntic
• Ferring Pharma
• Numaferm
• Hybio Pharmaceutical
• Provepharm Life Solutions
• Enzene Biosciences
• Ardena Holding
• Stelis Biopharma
• Piramal Pharma
• Space Peptides Pharmaceutical
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02
Market Dynamics:
Drivers:
The global peptide CDMO (pharmaceutical) services market is being propelled by the expanding therapeutic applications of peptides, advancements in healthcare technologies, and growing interest from pharmaceutical companies in peptide-based drug development.
Additional factors driving market growth include the rising prevalence of chronic diseases and an increasing consumer focus on health and wellness. To enhance operational efficiency and flexibility, many pharmaceutical companies are engaging in strategic collaborations to strengthen engineering, development, and manufacturing capabilities for peptide production. These dynamics are expected to sustain robust growth in the peptide CDMO market over the forecast period.
Challenges:
The market faces significant challenges related to the high costs and inherent complexity of peptide production. Peptide synthesis requires specialized equipment and technical expertise, as peptides are more difficult to manufacture than small-molecule compounds. The growing demand for peptide therapeutics highlights the need for efficient and scalable manufacturing processes. Moreover, elevated production costs may restrict access to peptide-based therapies in certain regions.
Despite their therapeutic potential, delivery mechanisms such as cell-penetrating peptides transport only a portion of the administered dose to target cells, with the remainder subject to metabolism or degradation, thereby reducing treatment efficacy and raising concerns regarding drug utilization. Additionally, the COVID-19 pandemic disrupted global supply chains, caused workforce shortages, and increased demand for diverse products, necessitating careful management of machinery and production capacity.
Regional Trends:
The North American peptide CDMO market is projected to secure a substantial revenue share and demonstrate strong growth, supported by advancements in biosynthesis technologies and the expanding chemical and pharmaceutical sectors. Ongoing research and development, particularly in genomics and personalized therapeutics, is further driving demand for specialized CDMO services. Europe also represents a significant market, fueled by a large patient population, rising healthcare expenditures, and heightened interest from multinational corporations seeking to capitalize on opportunities within the peptide CDMO sector.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1202
Recent Developments:
• In March 2024, Ferring Pharmaceuticals and SK Pharmateco reached a partnership to increase the industrial production capability of Adstiladrin (nadofaragene firadenovec-vncg), the medication used in Ferring's intravesical genetic therapy.
• In August 2024, AmbioPharma revealed its selection of Brian Gregg, a business veteran, as its new CEO. Mr. Gregg takes over from Tim Nieters, who is leaving the business after seven seasons and has a long history of expertise in the peptide CDMO sector.
Segmentation of Peptide CDMO (Pharmaceutical) Market-
By Scale of Operation-
• Preclinical
• Clinical
• Commercial
By Method Used-
• Chemical Synthesis Method
• Non-Chemical Synthesis Method
By Applications-
• Peptide Supplements
• Peptide Vaccines
• Peptides as Radio-theranostic Agents
• Cell-penetrating Peptides (CPPs)
• Affinity Ligands
• Protein Mimics
By Synthesis Types-
• LPPS
• SPPS
• Mixed Phase
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/global-peptide-cdmo-pharmaceutical-market-/1202
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide CDMO Pharmaceutical Market Outlook Regional Insights North America Europe and Asia Pacific here
News-ID: 4149147 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Rare Earth Magnet Market Size, Share and Trends Analysis Report 2025-2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Rare Earth Magnet Market- (By Type (Neodymium-Iron-Boron Magnet (NdFeB), Samarium Cobalt Magnet (SmCo)), Product (Countersunk Magnets, Circular Disc Magnets, Hook & Eyebolt Magnets, Cylindrical Rod Magnets, Circular Ring Magnets, Rectangular, Self-Adhesive, Pot & Clamping Magnets), Application (Automotive Industry, Food & Drink Processing, Aerospace Industry, Renewable Energy, Consumer Electronics, Deep Sea Exploration, Others)), Trends, Industry Competition…
Partially Hydrolyzed Polyacrylamide (PHPA) Market Survey Detailed Analysis and F …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Partially Hydrolyzed Polyacrylamide (PHPA) Market- (By Type (Anionic, Cationic, Non-ionic, Others), By Function (Viscosifying Agent, Shale bore-hole Stabilizer, Excapsulator, Flocculation Agent, Others), By Application (Drilling Fluids, Water Treatment Additive, Soil Stabilization, Paper Manufacturing, Others), By End-Use (Oil & Gas, Waste Water Treatment, Mining, Agriculture, Paper, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According…
Modular Construction Market expected to Witness Huge Revenue Growth to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Modular Construction Market Size, Share & Trends Analysis Report By Type (permanent, relocatable), Module (Four-Sided Modules, Open-Sided Modules, Partially Open Sided Modules, Mixed Modules & Floor Cassettes, Modules Supported By a Primary Structure), Material (steel, wood, concrete), End-user (residential, office, education, retail & commercial, hospitality, healthcare), Region, Market Outlook And Industry Analysis 2034"
The global modular…
Metal Recycling Market Current Scenario with Future Trends Analysis to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Metal Recycling Market- (By Type (Ferrous, Non-Ferrous Metals), By Equipment (Shredders, Shears, Granulating Machines, Briquetting Machines), By End-User (Building and Construction, Packaging, Automotive, Shipbuilding, Electronics Equipment, Electrical Equipment)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Metal Recycling Market Size is valued at 549.4…
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
